The Valley Desk

ArticleEuropean urologyPublished

Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study

14 of 120 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, University of Pennsylvania, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
European urology
Published
Subject terms
Humans; Prostatic Neoplasms; Genetic Predisposition to Disease; Kallikreins; Prostate-Specific Antigen; BRCA1 Protein; BRCA2 Protein; Neoplasm Staging; Incidence; Heterozygote; Germ-Line Mutation; Genes, BRCA1
PubMed ID
41714267
PubMed Central ID
PMC13401181
Added to directory
Source checked

Report a correction or request removal